IoM Pediatric Report Calls For Congressional Action, Better Collaboration
This article was originally published in The Gray Sheet
Executive Summary
Improving FDA postmarket surveillance capabilities will require congressional intervention in addition to other non-legislative measures, an Institute of Medicine report on pediatric device regulation issued July 18 suggests